Since recent studies have shown that IL-31 and its interaction with IL-31RA play a crucial role in the development of AD [7,11], clarifying the regulatory mechanism of IL-31RA expression under Th2-deviated conditions is very useful for treating AD. This evidence concerns the gene IL31RA and Alzheimer disease.